3-29-07 (A-19-06)
Michigan law applies to the failure-to-warn claim brought by a
Michigan resident alleging injuries in Michigan involving an FDA-approved prescription drug prescribed and used in Michigan. Michigan’s interest in promoting the availability of affordable prescription medications to its citizens outweighs New Jersey’s interest in deterring New Jersey corporations from providing inadequate warnings.
